Substance Use and Addiction Research

Alan David Kaye, MD, PhD, is the Professor and Chairman of the Department of Anesthesiology at LSU Health Sciences Center in New Orleans since January 2005. He is Board Certified as a Consultant in Anesthesiology and has a special certificate in Pain Management for the American Board of Anesthesiology. He is also a Diplomate of the American Board of Pain Medicine and the American Board of Interventional Pain Physicians. His PhD is in pharmacology, and he was awarded first place in the National Student Research Forum as a resident. He has authored or co-authored over 150 abstracts and 200 manuscripts and book chapters in the fields of pulmonary vascular pharmacology and anesthesiology. He serves on a number of national committees including as a National Board of Directors of ASIPP and ABIPP. He is editor-in-chief of the journal Pain Physicians and is on the FDA Advisory Board on Anesthetics and Analgesics. Richard D. Urman, MD, MBA, FASA is a staff anesthesiologist at the Brigham and Women’s Hospital in Boston, MA and Associate Professor of Anesthesia at Harvard Medical School. He currently serves as Associate Chair for Dana-Farber Cancer Institute, as well as Medical Director of Sedation for Interventional Medicine, Director, Center for Perioperative Research (C.P.R.), and Perioperative Medicine Fellowship Director. He is also the founder of the Incubator for Patient Safety and Outcomes (IPSO). Dr. Urman received his MD from Harvard Medical School and MBA from Harvard Business School, and completed a residency in anesthesia at Beth Israel Deaconess Medical Center. On the national level, Dr. Urman currently serves on various committees of the American Society of Anesthesiologists (ASA) including as Chair of the subcommittee on Patient Safety and Practice Management, Foundation of Anesthesia Education and Research (FAER), Society for Preoperative Assessment and Quality Improvement, and Enhanced Recovery After Surgery-USA.

• Basics of Research Methodology 1. Reliability and validity in substance abuse and addiction research2. Animal models3. Translational research strategies4. Experimental design in clinical trials Part 15. Experimental design in clinical trials Part 26. Qualitative and quantitative methods7. Ethical issues in opioids, alcohol, other drugs and addiction-related research: 8. Informatics9. Artificial intelligence and machine learning10. Epidemiology and health services research methods11. Imaging 12. Systematic review and meta-analysisMechanisms of abuse and addiction 13. Abuse and addiction14. Assessment of addiction/pain and neurobiology15. Physiological considerations in opioid addiction16. Basic pharmacology - opioid substances17. Basic pharmacology - non-opioid substances18. Types of addiction19. Substance use 20. Special study populationsInvestigative Therapeutics: Designing studies and measuring outcomes21. General therapy strategies in substance addiction22. Alternative Therapy Strategies in Addiction23. Drug testing and adherence monitoring24. Pharmacogenetics - Genes, genetics, genomics and epigenetics25. Novel therapeutic strategies effectiveness26. Methods of psychosocial interventions27. Principles of vaccine development28. Drug policy analysis29. Implementation science: Theories, models and frameworks30. Designing and testing population-based prevention programs31. New vistas in research